disertacija
Cytotoxic and immunosuppressive inflammatory cells predict regression and prognosis following neoadjuvant radio chemotherapy of esophageal adenocarcinoma
Split: Sveučilište u Splitu, Medicinski fakultet, 2023. urn:nbn:hr:171:883713

Sveučilište u Splitu
Medicinski fakultet

Citirajte ovaj rad

Göbel, H. (2023). Cytotoxic and immunosuppressive inflammatory cells predict regression and prognosis following neoadjuvant radio chemotherapy of esophageal adenocarcinoma (Disertacija). Split: Sveučilište u Splitu, Medicinski fakultet. Preuzeto s https://urn.nsk.hr/urn:nbn:hr:171:883713

Göbel, Holger. "Cytotoxic and immunosuppressive inflammatory cells predict regression and prognosis following neoadjuvant radio chemotherapy of esophageal adenocarcinoma." Disertacija, Sveučilište u Splitu, Medicinski fakultet, 2023. https://urn.nsk.hr/urn:nbn:hr:171:883713

Göbel, Holger. "Cytotoxic and immunosuppressive inflammatory cells predict regression and prognosis following neoadjuvant radio chemotherapy of esophageal adenocarcinoma." Disertacija, Sveučilište u Splitu, Medicinski fakultet, 2023. https://urn.nsk.hr/urn:nbn:hr:171:883713

Göbel, H. (2023). 'Cytotoxic and immunosuppressive inflammatory cells predict regression and prognosis following neoadjuvant radio chemotherapy of esophageal adenocarcinoma', Disertacija, Sveučilište u Splitu, Medicinski fakultet, citirano: 22.02.2024., https://urn.nsk.hr/urn:nbn:hr:171:883713

Göbel H. Cytotoxic and immunosuppressive inflammatory cells predict regression and prognosis following neoadjuvant radio chemotherapy of esophageal adenocarcinoma [Disertacija]. Split: Sveučilište u Splitu, Medicinski fakultet; 2023 [pristupljeno 22.02.2024.] Dostupno na: https://urn.nsk.hr/urn:nbn:hr:171:883713

H. Göbel, "Cytotoxic and immunosuppressive inflammatory cells predict regression and prognosis following neoadjuvant radio chemotherapy of esophageal adenocarcinoma", Disertacija, Sveučilište u Splitu, Medicinski fakultet, Split, 2023. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:171:883713

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.